The effects of carnosine on oxidative DNA damage levels and in vitro lifespan in human peripheral blood derived CD4+T cell clones

Carnosine (beta-alanyl-L-histidine), an abundant naturally-occurring dipeptide has been shown to exhibit anti-ageing properties towards cultured cells, possibly due in part to its antioxidant/free radical scavenging abilities. In this paper the results of an investigation on the effects of carnosine, at the physiological concentration of 20 mM, on oxidative DNA damage levels and in vitro lifespan in peripheral blood derived human CD4+ T cell clones are reported. Under the culture conditions used (20% O(2)) long term culture with carnosine resulted in a significant increase in the lifespan of a clone derived from a healthy young subject. No such extension was observed when a T cell clone from a healthy old SENIEUR donor was similarly cultured. Culture with carnosine from the midpoint of each clone's lifespan did not have any effect on longevity, independent of donor age. Oxidative DNA damage levels were measured in the clones at various points in their lifespans. Carnosine acted as a weak antioxidant, with levels of oxidative DNA damage being lower in T cells grown long term in the presence of carnosine. The possibility that carnosine might confer anti-ageing effects to T cells under physiological oxygen tensions would appear to be worthy of further investigation.

[1]  R. Holliday,et al.  Retardation of the senescence of cultured human diploid fibroblasts by carnosine. , 1994, Experimental cell research.

[2]  Y. Barnett,et al.  An investigation of antioxidant status, DNA repair capacity and mutation as a function of age in humans. , 1995, Mutation research.

[3]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[4]  H. Joenje,et al.  Effect of antioxidants on hyperoxia-induced chromosomal breakage in Chinese hamster ovary cells: protection by carnosine , 1991 .

[5]  E. S. Gillespie,et al.  In vivo antioxidant status, DNA damage, mutation and DNA repair capacity in cultured lymphocytes from healthy 75- to 80-year-old humans. , 1997, Mutation research.

[6]  A. Hipkiss,et al.  Carnosine protects proteins against methylglyoxal-mediated modifications. , 1998, Biochemical and biophysical research communications.

[7]  K. Kunze,et al.  Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle biopsies and rat muscles. , 1999, Archives of gerontology and geriatrics.

[8]  Y. Barnett,et al.  DNA damage and mutation: contributors to the age-related alterations in T cell-mediated immune responses? , 1998, Mechanisms of Ageing and Development.

[9]  C. Fitzgerald,et al.  Carnosine prevents glyceraldehyde 3-phosphate-mediated inhibition of aspartate aminotransferase , 1999, Archives of Toxicology.

[10]  A. Hipkiss,et al.  Pluripotent Protective Effects of Carnosine, a Naturally Occurring Dipeptidea , 1998, Annals of the New York Academy of Sciences.

[11]  R. Holliday,et al.  Further evidence for the rejuvenating effects of the dipeptide l-carnosine on cultured human diploid fibroblasts , 1999, Experimental Gerontology.

[12]  P. Syrris,et al.  Non‐enzymatic glycosylation of the dipeptide l‐carnosine, a potential anti‐protein‐cross‐linking agent , 1995, FEBS letters.

[13]  R. Cunningham,et al.  Purification and characterization of Escherichia coli endonuclease III from the cloned nth gene. , 1989, Biochemistry.

[14]  E. S. Gillespie,et al.  An investigation of mutation as a function of age in humans. , 1994, Mutation research.

[15]  R. Holliday,et al.  Carnosine and senescence , 1993 .

[16]  A. Collins,et al.  Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. , 1993, Carcinogenesis.

[17]  P. Quinn,et al.  Carnosine: its properties, functions and potential therapeutic applications. , 1992, Molecular aspects of medicine.

[18]  D. Knook,et al.  Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the senieur protocol , 1990, Mechanisms of Ageing and Development.

[19]  G. Pawelec.  EUCAMBIS: Immunology and Ageing in Europe , 2000 .

[20]  J. Thome,et al.  Advanced glycation endproducts in ageing and Alzheimer's disease , 1997, Brain Research Reviews.

[21]  K. Trieb,et al.  Long-term in vitro growth of human T cell clones: can postmitotic 'senescent' cell populations be defined? , 1994, International archives of allergy and immunology.

[22]  J. Vinson,et al.  Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients , 1996 .

[23]  M. O'Kane,et al.  Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. , 2000, Mutation research.

[24]  B. Ames,et al.  Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  G. Pawelec,et al.  T-cell immunosenescence and its clinical relevance in man , 1998 .

[26]  A. Hipkiss,et al.  Protective effects of carnosine against protein modification mediated by malondialdehyde and hypochlorite. , 1998, Biochimica et biophysica acta.

[27]  A. Hipkiss.  Carnosine, a protective, anti-ageing peptide? , 1998, The international journal of biochemistry & cell biology.

[28]  R. Holliday,et al.  Inhibition of the growth of transformed and neoplastic cells by the dipeptide carnosine. , 1996, British Journal of Cancer.

[29]  A. Hipkiss,et al.  A possible new role for the anti-ageing peptide carnosine , 2000, Cellular and Molecular Life Sciences CMLS.

[30]  E. Gajewski,et al.  Substrate specificity of the Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): excision of purine lesions in DNA produced by ionizing radiation or photosensitization. , 1992, Biochemistry.

[31]  A. Collins,et al.  Oxidative DNA damage in human cells: the influence of antioxidants and DNA repair. , 1997, Biochemical Society transactions.

[32]  S. Watabe,et al.  Carnosine sustains the retention of cell morphology in continuous fibroblast culture subjected to nutritional insult. , 1996, Biochemical and biophysical research communications.

[33]  G. Pawelec,et al.  Human T‐cell clones in long‐term culture as a model of immunosenescence , 1997, Immunological reviews.

[34]  B. Ames,et al.  Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Kuleva Nv,et al.  Change in the functional properties of actin by its glycation in vitro. , 1997 .